Neuronal NAMPT is released after cerebral ischemia and protects against white matter injury

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 10, 2014, Pages 1613-1621

  Jing, Zheng ^a,b   Xing, Juan ^a,b   Chen, Xinzhi ^a,b   Stetler, Ruth A ^b   Weng, Zhongfang ^b   Gan, Yu ^b   Zhang, Feng ^b   Gao, Yanqin ^c   Chen, Jun ^a,b   Leak, Rehana K ^d   Cao, Guodong ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c FUDAN UNIVERSITY   (China)

^d DUQUESNE UNIVERSITY   (United States)

Author keywords

NAMPT; NAMPT secretion; neuroprotection; oligodendrocytes; transient MCAO; white matter injury

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; EMBRYO; ENZYME RELEASE; IN VITRO STUDY; MALE; MOUSE; MYELINATED NERVE; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; WHITE MATTER INJURY; ANIMAL; C57BL MOUSE; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; TRANSGENIC MOUSE; UPREGULATION; WHITE MATTER;

ANIMALS; BRAIN ISCHEMIA; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; UP-REGULATION; WHITE MATTER;

EID: 84921742607     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.119     Document Type: Article

References (27)

1. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998; 4: 291-297.
2. Correa F, Gauberti M, Parcq J, Macrez R, Hommet Y, Obiang P et al. Tissue plasminogen activator prevents white matter damage following stroke. J Exp Med 2011; 208: 1229-1242.
3. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996; 27: 1641-1646, discussion 1647.
4. Ho PW, Reutens DC, Phan TG, Wright PM, Markus R, Indra I et al. Is white matter involved in patients entered into typical trials of neuroprotection? Stroke 2005; 36: 2742-2744.
5. Desmond DW. Cognition and white matter lesions. Cerebrovasc Dis 2002; 13(Suppl 2): 53-57.
6. Leys D, Englund E, Del Ser T, Inzitari D, Fazekas F, Bornstein N et al. White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur Neurol 1999; 42: 67-75.
7. Pantoni L, Leys D, Fazekas F, Longstreth Jr. WT, Inzitari D, Wallin A et al. Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord 1999; 13(Suppl 3): S49-S54.
8. Arai K, Lo EH. Experimental models for analysis of oligodendrocyte pathophysiology in stroke. Exp Transl Stroke Med 2009; 1: 6.
9. Imai S. The NAD World: a new systemic regulatory network for metabolism and aging-Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys 2009; 53: 65-74.
10. Magni G, Amici A, Emanuelli M, Raffaelli N, Ruggieri S. Enzymology of NAD synthesis. Adv Enzymol Relat Areas Mol Biol 1999; 73: 135-182xi.
11. Wang P, Xu TY, Guan YF, Tian WW, Viollet B, Rui YC et al. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol 2011; 69: 360-374.
12. Zhang W, Xie Y, Wang T, Bi J, Li H, Zhang LQ et al. Neuronal protective role of PBEF in a mouse model of cerebral ischemia. J Cereb Blood Flow Metab 2010; 30: 1962-1971.
13. Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A et al. Nampt/PBEF/ Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007; 6: 363-375.
14. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49: 744-747.
15. Friebe D, Neef M, Kratzsch J, Erbs S, Dittrich K, Garten A et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/ pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011; 54: 1200-1211.
16. Garten A, Petzold S, Barnikol-Oettler A, Korner A, Thasler WE, Kratzsch J et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem Biophys Res Commun 2010; 391: 376-381.
17. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR et al. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J Neurosci 2002; 22: 5423-5431.
18. Gan Y, Xing J, Jing Z, Stetler RA, Zhang F, Luo Y et al. Mutant erythropoietin without erythropoietic activity is neuroprotective against ischemic brain injury. Stroke 2012; 43: 3071-3077.
19. Chen Y, Balasubramaniyan V, Peng J, Hurlock EC, Tallquist M, Li J et al. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc 2007; 2: 1044-1051.
20. Patani R, Balaratnam M, Vora A, Reynolds R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol 2007; 33: 277-287.
21. Schubert K, Gutknecht D, Koberle M, Anderegg U, Saalbach A. Melanoma cells use Thy-1 (CD90) on endothelial cells for metastasis formation. Am J Pathol 2013; 182: 266-276.
22. Ades EW, Zwerner RK, Acton RT, Balch CM. Isolation and partial characterization of the human homologue of Thy-1. J Exp Med 1980; 151: 400-406.
23. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40: 1849-1857.
24. Song J, Ke SF, Zhou CC, Zhang SL, Guan YF, Xu TY et al. Nicotinamide phosphoribosyltransferase is required for the calorie restriction-mediated improvements in oxidative stress, mitochondrial biogenesis, and metabolic adaptation. J Gerontol A Biol Sci Med Sci 2014; 69: 44-57.
25. Schilling E, Wehrhahn J, Klein C, Raulien N, Ceglarek U, Hauschildt S. Inhibition of nicotinamide phosphoribosyltransferase modifies LPSinduced inflammatory responses of human monocytes. Innate Immun 2012; 18: 518-530.
26. Frost SB, Barbay S, Mumert ML, Stowe AM, Nudo RJ. An animal model of capsular infarct: endothelin-1 injections in the rat. Behav Brain Res 2006; 169: 206-211.
27. Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004; 35: 2598-2603.